Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve (BICATOR)

NCT02679261 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT02679261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02679261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve (BICATOR)
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2016
Completion date
February 28, 2021
Enrollment
220 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

bicuspid aortic valve